These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31630338)

  • 1. Influence of Prevalent Vertebral Fracture on the Correlation between Change in Lumbar Spine Bone Mineral Density and Risk of New Vertebral Fracture: A Meta-Analysis of Randomized Clinical Trials.
    Kobayashi T; Kaneko M; Narukawa M
    Clin Drug Investig; 2020 Jan; 40(1):15-23. PubMed ID: 31630338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the Influencing Factors on the Incidence of Vertebral Fracture: A Meta-analysis Based on Placebo Data of Randomized Clinical Trials.
    Kobayashi T; Kaneko M; Narukawa M
    Ther Innov Regul Sci; 2020 Jan; 54(1):240-245. PubMed ID: 32008236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.
    Sarkar S; Mitlak BH; Wong M; Stock JL; Black DM; Harper KD
    J Bone Miner Res; 2002 Jan; 17(1):1-10. PubMed ID: 11771654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence on adjacent lumbar bone density after strengthening of T12, L1 segment vertebral osteoporotic compression fracture by percutaneous vertebroplasty and percutaneous kyphoplasty].
    Zhang C; Zhu K; Zhou J; Zhou X; Niu G; Wu M; Shao C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):819-23. PubMed ID: 24063170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis.
    Okubo N; Matsui S; Matsumoto T; Sugimoto T; Hosoi T; Osakabe T; Watanabe K; Takami H; Shiraki M; Nakamura T
    Calcif Tissue Int; 2020 Dec; 107(6):559-566. PubMed ID: 32839843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy.
    Rehman Q; Lang T; Modin G; Lane NE
    Arthritis Rheum; 2002 May; 46(5):1292-7. PubMed ID: 12115236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug efficacies on bone mineral density and fracture rate for the treatment of postmenopausal osteoporosis: a network meta-analysis.
    Yang L; Kang N; Yang JC; Su QJ; Liu YZ; Guan L; Liu T; Meng XL; Wang Y; Hai Y
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2640-2668. PubMed ID: 30964193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group.
    Nevitt MC; Ross PD; Palermo L; Musliner T; Genant HK; Thompson DE
    Bone; 1999 Nov; 25(5):613-9. PubMed ID: 10574584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced prediction of fracture risk combining vertebral fracture status and BMD.
    Siris ES; Genant HK; Laster AJ; Chen P; Misurski DA; Krege JH
    Osteoporos Int; 2007 Jun; 18(6):761-70. PubMed ID: 17245546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of hip bone mineral density over time is associated with spine and hip fracture incidence in osteoporotic postmenopausal women.
    Bruyere O; Varela AR; Adami S; Detilleux J; Rabenda V; Hiligsmann M; Reginster JY
    Eur J Epidemiol; 2009; 24(11):707-12. PubMed ID: 19728118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increases in hip and spine bone mineral density are predictive for vertebral antifracture efficacy with ibandronate.
    Miller PD; Delmas PD; Huss H; Patel KM; Schimmer RC; Adami S; Recker RR
    Calcif Tissue Int; 2010 Oct; 87(4):305-13. PubMed ID: 20737140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
    Shetty S; John B; Mohan S; Paul TV
    Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
    O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risedronate decreases fracture risk in patients selected solely on the basis of prior vertebral fracture.
    Kanis JA; Barton IP; Johnell O
    Osteoporos Int; 2005 May; 16(5):475-82. PubMed ID: 15875093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
    Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
    JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis.
    Chen P; Miller PD; Delmas PD; Misurski DA; Krege JH
    J Bone Miner Res; 2006 Nov; 21(11):1785-90. PubMed ID: 17002571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New or worsening lumbar spine vertebral fractures increase lumbar spine bone mineral density and falsely suggest improved skeletal status.
    Krege JH; Miller PD; Lenchik L; Misurski DA; Chen P
    J Clin Densitom; 2006; 9(2):144-9. PubMed ID: 16785072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.
    Bouxsein ML; Eastell R; Lui LY; Wu LA; de Papp AE; Grauer A; Marin F; Cauley JA; Bauer DC; Black DM;
    J Bone Miner Res; 2019 Apr; 34(4):632-642. PubMed ID: 30674078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.